Lower-concentration prostaglandin analogue may reduce adverse effects

HYDERABAD, India — A 0.01% concentration of bimatoprost showed comparable efficacy and significantly improved tolerability compared to the standard 0.03% formulation.“Prostaglandin analogues are first-line therapy for glaucoma, as they have shown the best efficacy in reducing IOP with a single daily administration. However, side effects such as hyperemia and itchy sensation are common complaints,” Barun K. Nayak, MD, said in an industry-sponsored symposium at the joint meeting of the Asia-Pacific Academy of Ophthalmology and All India Ophthalmological Society.

Full Story →